Celularity (CELU) vs Dogwood Therapeutics (DWTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Celularity (CELU) has outperformed Dogwood Therapeutics (DWTX) over the past year, losing 27.9% versus a loss of 78.8%. Over five years, CELU leads with a -98.0% price change compared with -98.8% for DWTX. Dogwood Therapeutics is the larger company by market cap ($49.6 million vs $47.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CELU | DWTX |
|---|---|---|
| Share price | $1.45 | $1.46 |
| Market cap | $47.07M | $49.63M |
| 1-day change | -1.32% | +2.10% |
| YTD return | +32.43% | -65.63% |
| 1-year return | -27.94% | -78.85% |
| 5-year return | -97.96% | -98.78% |
| P/E ratio (TTM) | — | 0.66 |
| EPS (TTM) | $-2.73 | $2.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.55 | $7.04 |
| 52-week low | $0.56 | $1.28 |
| Distance from 52-week high | -43.11% | -79.27% |
| Average volume | 3.89M | 63.03K |
| Shares outstanding | 32.45M | 33.99M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CELU has outperformed DWTX by 50.9 percentage points over the past year.
CELU vs DWTX FAQ
Which is bigger, Celularity or Dogwood Therapeutics?
Dogwood Therapeutics (DWTX) is larger, with a market capitalization of $49.63M compared with $47.07M for Celularity (CELU).
Which stock has performed better over the past year, CELU or DWTX?
CELU returned -27.94% over the past 12 months, compared with -78.85% for DWTX (price return, excluding dividends). Past performance does not predict future results.
Are Celularity and Dogwood Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.